Executive Management Team
VP of Business Development
Lorelei is a graduate from the University of Toronto with a Bachelor of Science (Honors) degree specializing in human biology and nutritional sciences with an MBA degree from York University. Lorelei is the Secretary of the Canadian Society for Pharmaceutical Sciences (CSPS) and an active member of various associations such as AAPS and GPhA.
She is responsible for overall sales which include identifying and implementing all sales, marketing and external communication activities throughout North America, Europe and Asia.
Chief Financial Officer
Graduated as a Chartered Accountant with Institute of Chartered Accountants of Ontario and worked in a number of organizations both in the manufacturing and service industry with revenues up to $40 Million.
With over 20 years of experience managing and training staff in multi locations throughout North America, Wendy also implemented controls to reduce risk of fraud, set up accounting systems and streamlined them to meet the reporting needs of the board.
VP of Scientific Affairs
With a PhD and post-doctoral training in Physiology-Pharmacology at the Faculty of Pharmacy at the University of Montreal, Fethi has extensive experience in early clinical phase 1-2a drug development, including studies for PK/PD bioequivalence, Phase 1 SAD/MAD integrated design, Food effect, QTc, drug-drug interaction, Study in renal-impaired patients and Biosimilar development.
He is an expert in Hybrid generic/505(b)(2) programs for EU and USA NDA submissions from initial Pre-IND meetings up until the NDA submission to the agency and also well versed in Biosimilar early clinical development study design for PK/PD evaluation.